Other OTC - Delayed Quote • USD
Urologix, Inc. (ULGX)
At close: March 8 at 9:48 AM EST
Breakdown
TTM
Total Revenue
12,190.0000
Cost of Revenue
6,370.0000
Gross Profit
5,820.0000
Operating Expense
6,720.0000
Operating Income
-900.0000
Net Non Operating Interest Income Expense
-771.0000
Other Income Expense
-3,050.0000
Pretax Income
-4,721.0000
Tax Provision
-53.0000
Net Income Common Stockholders
-4,668.0000
Diluted NI Available to Com Stockholders
-4,668.0000
Basic EPS
-0.22
Diluted EPS
-0.22
Basic Average Shares
21,598.5000
Diluted Average Shares
21,598.5000
Total Operating Income as Reported
-3,936.0000
Total Expenses
13,090.0000
Net Income from Continuing & Discontinued Operation
-4,668.0000
Normalized Income
-1,652.2406
Net Interest Income
-771.0000
EBIT
-1,018.0000
EBITDA
-517.0000
Reconciled Cost of Revenue
5,948.0000
Reconciled Depreciation
501.0000
Net Income from Continuing Operation Net Minority Interest
-4,668.0000
Total Unusual Items Excluding Goodwill
-3,050.0000
Total Unusual Items
-3,050.0000
Normalized EBITDA
2,533.0000
Tax Rate for Calcs
0.0000
Tax Effect of Unusual Items
-34.2406
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ESMC Escalon Medical Corp.
0.2000
-16.67%
UAHC United American Healthcare Corporation
0.0266
0.00%
FORZ Forza Innovations Inc.
0.0001
0.00%
TIVC Tivic Health Systems, Inc.
1.0400
-3.70%
VIVE Viveve Medical, Inc.
0.0002
-33.33%
CTSO Cytosorbents Corporation
0.8190
+1.24%
IRIX IRIDEX Corporation
2.8700
-3.04%
OPGN OpGen, Inc.
0.5149
-3.21%